Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention††Conflicts of interest: Dr. Angiolillo is a consultant and on the speaker’s bureau for Bristol Myers Squibb, New York, New York, and Sanofi-Aventis, Paris, France. Dr. Biondi-Zoccai has consulted for Boston Scientific, Natick, Massachusetts, and Cordis, Miami, Florida, and received lecture fees from Bristol Myers Squibb. Dr. Montalescot has been a consultant for and/or received research grants from Sanofi-Aventis.

Journal article published in 2007 by Marzia Lotrionte, Giuseppe G. L. Biondi-Zoccai, Pierfrancesco Agostoni, Antonio Abbate, Dominick J. Angiolillo, Marco Valgimigli, Claudio Moretti, Emanuele Meliga, Thomas Cuisset, Marie-Christine Alessi, Gilles Montalescot, Jean-Philippe Collet, Germano Di Sciascio , Ron Waksman, Luca Testa and other authors. Marzia Lotrionte, Giuseppe G. L. Biondi-Zoccai, Pierfrancesco Agostoni, Antonio Abbate, Dominick J. Angiolillo, Marco Valgimigli, Claudio Moretti, Emanuele Meliga, Thomas Cuisset, Marie-Christine Alessi, Gilles Montalescot, Jean-Philippe Collet, Germano Di Sciascio , Ron Waksman, Luca Testa, Giuseppe Sangiorgi , Antonio Laudito, Gian P. Trevi, Imad Sheiban

Show less

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by